Top segments and regional performance

Last year, the company generated 441.00 k USD, the most of which — 441.00 k USD — came from its top-performing segment, Pharmaceutical, compared to 1.92 M USD the previous year. The greatest contribution came from United States, which accounted for 441.00 k USD last year, with 1.92 M USD the year before.